Header Logo

Connection

LAURA MARSH to Male

Back to Details
This is a "connection" page, showing publications LAURA MARSH has written about Male.
LAURA MARSH
Connection Strength
0.343
Male
  1. Pharmacologic treatment of anxiety disorders in Parkinson disease. Am J Geriatr Psychiatry. 2013 Jun; 21(6):520-8.
    View in: PubMed
    Score: 0.018
  2. Improving detection of psychiatric disturbances in Parkinson's disease: the role of informants. J Parkinsons Dis. 2013; 3(1):55-60.
    View in: PubMed
    Score: 0.018
  3. Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety. J Parkinsons Dis. 2013; 3(4):603-8.
    View in: PubMed
    Score: 0.018
  4. Anxiety disorders, physical illnesses, and health care utilization in older male veterans with Parkinson disease and comorbid depression. J Geriatr Psychiatry Neurol. 2012 Dec; 25(4):233-9.
    View in: PubMed
    Score: 0.017
  5. Prevalence of psychotic symptoms in a community-based Parkinson disease sample. Am J Geriatr Psychiatry. 2012 Feb; 20(2):123-32.
    View in: PubMed
    Score: 0.016
  6. Familial aggregation of panic disturbances in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2011; 23(4):417-24.
    View in: PubMed
    Score: 0.015
  7. Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1333-8.
    View in: PubMed
    Score: 0.014
  8. Validity of the Cornell scale for depression in dementia in Parkinson's disease with and without cognitive impairment. Mov Disord. 2009 Feb 15; 24(3):433-7.
    View in: PubMed
    Score: 0.013
  9. Atomoxetine for the treatment of executive dysfunction in Parkinson's disease: a pilot open-label study. Mov Disord. 2009 Jan 30; 24(2):277-82.
    View in: PubMed
    Score: 0.013
  10. Pilot screening for prodromal Parkinson's disease in post-9/11 Veterans with probable rapid eye movement sleep behavior disorder. Parkinsonism Relat Disord. 2025 Mar; 132:107309.
    View in: PubMed
    Score: 0.010
  11. Randomized placebo-controlled trial of donepezil in cognitive impairment in Parkinson's disease. Int J Geriatr Psychiatry. 2004 Jan; 19(1):1-8.
    View in: PubMed
    Score: 0.009
  12. Hippocampal volume deficits in alcoholic Korsakoff's syndrome. Neurology. 2003 Dec 23; 61(12):1716-9.
    View in: PubMed
    Score: 0.009
  13. Dystonia and Tremor: A Cross-Sectional Study of the Dystonia Coalition Cohort. Neurology. 2021 01 26; 96(4):e563-e574.
    View in: PubMed
    Score: 0.008
  14. Accuracy of the PHQ-2 Alone and in Combination With the PHQ-9 for Screening to Detect Major Depression: Systematic Review and Meta-analysis. JAMA. 2020 06 09; 323(22):2290-2300.
    View in: PubMed
    Score: 0.007
  15. Post-Traumatic Stress Disorder is Associated with further Increased Parkinson's Disease Risk in Veterans with Traumatic Brain Injury. Ann Neurol. 2020 07; 88(1):33-41.
    View in: PubMed
    Score: 0.007
  16. Patient Health Questionnaire-9 scores do not accurately estimate depression prevalence: individual participant data meta-analysis. J Clin Epidemiol. 2020 06; 122:115-128.e1.
    View in: PubMed
    Score: 0.007
  17. Clinical Correlates of Dream Enactment Behaviors in Previously Deployed OEF/OIF/OND Veterans: An Exploratory Analysis. J Neuropsychiatry Clin Neurosci. 2020; 32(2):147-153.
    View in: PubMed
    Score: 0.007
  18. Probability of major depression diagnostic classification using semi-structured versus fully structured diagnostic interviews. Br J Psychiatry. 2018 06; 212(6):377-385.
    View in: PubMed
    Score: 0.006
  19. Cervical dystonia and substance abuse. J Neurol. 2018 Apr; 265(4):970-975.
    View in: PubMed
    Score: 0.006
  20. Perceived Treatment Status of Fluctuations in Parkinson Disease Impacts Suicidality. Am J Geriatr Psychiatry. 2018 06; 26(6):700-710.
    View in: PubMed
    Score: 0.006
  21. Psychiatric associations of adult-onset focal dystonia phenotypes. J Neurol Neurosurg Psychiatry. 2017 07; 88(7):595-602.
    View in: PubMed
    Score: 0.006
  22. Active Mental Illnesses Adversely Affect Surgical Outcomes. Am Surg. 2016 Dec 01; 82(12):1238-1243.
    View in: PubMed
    Score: 0.006
  23. Factors Associated With Veterans' Access to Permanent Supportive Housing. Psychiatr Serv. 2016 08 01; 67(8):870-7.
    View in: PubMed
    Score: 0.005
  24. Modeling anxiety in Parkinson's disease. Mov Disord. 2016 Mar; 31(3):310-6.
    View in: PubMed
    Score: 0.005
  25. The longitudinal impact of depression on disability in Parkinson disease. Int J Geriatr Psychiatry. 2016 May; 31(5):458-65.
    View in: PubMed
    Score: 0.005
  26. Influence of schizophrenia diagnosis on providers' practice decisions. J Clin Psychiatry. 2015 Aug; 76(8):1068-74; quiz 1074.
    View in: PubMed
    Score: 0.005
  27. A Pilot Study of a Cognitive-Behavioral Treatment for Anxiety and Depression in Patients With Parkinson Disease. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):210-7.
    View in: PubMed
    Score: 0.005
  28. Apathy in Neurodegenerative Diseases: Recommendations on the Design of Clinical Trials. J Geriatr Psychiatry Neurol. 2015 Sep; 28(3):159-73.
    View in: PubMed
    Score: 0.005
  29. Mental health diagnoses and health care utilization in persons with dementia, Parkinson's disease, and stroke. J Neuropsychiatry Clin Neurosci. 2015; 27(2):e117-21.
    View in: PubMed
    Score: 0.005
  30. Alleviating manoeuvres (sensory tricks) in cervical dystonia. J Neurol Neurosurg Psychiatry. 2014 Aug; 85(8):882-4.
    View in: PubMed
    Score: 0.005
  31. Cognitive and motor function in long-duration PARKIN-associated Parkinson disease. JAMA Neurol. 2014 Jan; 71(1):62-7.
    View in: PubMed
    Score: 0.005
  32. Anxiety has specific syndromal profiles in Parkinson disease: a data-driven approach. Am J Geriatr Psychiatry. 2014 Dec; 22(12):1410-7.
    View in: PubMed
    Score: 0.005
  33. Modeling depression in Parkinson disease: disease-specific and nonspecific risk factors. Neurology. 2013 Sep 17; 81(12):1036-43.
    View in: PubMed
    Score: 0.005
  34. Rasch analysis of anxiety scales in Parkinson's disease. J Psychosom Res. 2013 May; 74(5):414-9.
    View in: PubMed
    Score: 0.004
  35. Cognitive behavioral therapy for depression and anxiety in Parkinson's disease: a clinical review. J Parkinsons Dis. 2012; 2(2):135-51.
    View in: PubMed
    Score: 0.004
  36. Ocular motor and sensory function in Parkinson's disease. Ophthalmology. 2012 Jan; 119(1):178-82.
    View in: PubMed
    Score: 0.004
  37. Anxiety rating scales in Parkinson's disease: a validation study of the Hamilton anxiety rating scale, the Beck anxiety inventory, and the hospital anxiety and depression scale. Mov Disord. 2011 Feb 15; 26(3):407-15.
    View in: PubMed
    Score: 0.004
  38. Symptomatology and markers of anxiety disorders in Parkinson's disease: a cross-sectional study. Mov Disord. 2011 Feb 15; 26(3):484-92.
    View in: PubMed
    Score: 0.004
  39. Neuropsychological Profile of Parkin Mutation Carriers with and without Parkinson Disease: The CORE-PD Study. J Int Neuropsychol Soc. 2011 Jan; 17(1):91-100.
    View in: PubMed
    Score: 0.004
  40. Frequency of known mutations in early-onset Parkinson disease: implication for genetic counseling: the consortium on risk for early onset Parkinson disease study. Arch Neurol. 2010 Sep; 67(9):1116-22.
    View in: PubMed
    Score: 0.004
  41. Predictors of parkin mutations in early-onset Parkinson disease: the consortium on risk for early-onset Parkinson disease study. Arch Neurol. 2010 Jun; 67(6):731-8.
    View in: PubMed
    Score: 0.004
  42. Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease. Arch Neurol. 2009 Dec; 66(12):1517-22.
    View in: PubMed
    Score: 0.004
  43. The course of depressive symptoms in early Parkinson's disease. Mov Disord. 2009 Jul 15; 24(9):1306-11.
    View in: PubMed
    Score: 0.003
  44. Morphometry of the human substantia nigra in ageing and Parkinson's disease. Acta Neuropathol. 2008 Apr; 115(4):461-70.
    View in: PubMed
    Score: 0.003
  45. Alpha-synuclein and Parkinson's disease: implications from the screening of more than 1,900 patients. Mov Disord. 2005 Sep; 20(9):1191-4.
    View in: PubMed
    Score: 0.003
  46. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging. 2005 Aug-Sep; 26(8):1183-92.
    View in: PubMed
    Score: 0.003
  47. Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease. Am J Psychiatry. 2002 Aug; 159(8):1306-14.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.